NCT03897725View on ClinicalTrials.gov

Evaluating The Acceptability and Uptake of Pre-Exposure Prophylaxis (PrEP) for Adolescent Women in The Deep South

NAWithdrawnINTERVENTIONAL

0

Timeline

Start Date

December 1, 2020

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions

Adolescent BehaviorHIV/AIDSPrEP

Interventions

OTHER

Telehealth Coaching

Telehealth coaching to promote adherence

Trial Locations (1)

35233

William A. Daniel Adolescent Health Center, Birmingham

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

University of Alabama at Birmingham

OTHER

NCT03897725 - Evaluating The Acceptability and Uptake of Pre-Exposure Prophylaxis (PrEP) for Adolescent Women in The Deep South | Biotech Hunter | Biotech Hunter